Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032577 · ClinicalTrials.gov registry record
A Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations
A clinical trial, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- 50
- Enrollment target
NCT01032577: Completed study, sponsored by Trinity Health Of New England.
NCT01032577 is a clinical trial that has completed, run by Trinity Health Of New England. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01032577 has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The PropR study will evaluate sensing during ventricular fibrillation (VF) in both bipolar and extended bipolar configurations, in order to evaluate if both can be used interchangeably in caring for patients. In addition, follow up evaluation of R wave amplitude over time would allow us to determine whether one configuration is more likely to be associated with change. This understanding would be important in selecting the proper configuration at the time of implant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-07 |
What the finished NCT01032577 record still lists
NCT01032577 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01032577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01032577 about?
NCT01032577 is a clinical study titled "A Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations". The PropR study will evaluate sensing during ventricular fibrillation (VF) in both bipolar and extended bipolar configurations, in order to evaluate if both can be used interchangeably in caring for patients. In addition, follow up evaluation of R wave amplitude over time would allow us to determine...
What is the current status of trial NCT01032577?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-12. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01032577?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia